MaxCyte, Inc. (MXCT)
1.155
+0.02
(+1.32%)
USD |
NASDAQ |
Jun 08, 15:51
MaxCyte Profit Margin (Quarterly) : -49.22% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Repligen Corp. | 4.29% |
| Bio-Techne Corp. | 16.39% |
| BioLife Solutions, Inc. | 4.31% |
| MindWalk Holdings Corp. | -94.52% |
| Maravai Lifesciences Holdings, Inc. | -9.69% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -21.50% |
| Return on Assets | -18.45% |
| Return on Invested Capital | -19.55% |
| Gross Profit Margin (Quarterly) | 73.22% |
| Operating Margin (Quarterly) | -64.96% |
| Return on Net Operating Assets | -85.58% |